Dechra Pharmaceuticals (DCHPF) Stock Price, News & Analysis

Company Overview

Dechra Pharmaceuticals is a specialty veterinary pharmaceutical company headquartered in the United Kingdom. Founded in 1997, the company develops, manufactures and markets medicines and nutritional products for companion animals, horses and livestock.

Its product portfolio includes treatments for conditions such as endocrine disorders, dermatology, pain and inflammation, anesthesia, fluid therapy and ophthalmology. Dechra also offers veterinary diets and nutritional products under brands including SPECIFIC, as well as a range of prescription medicines marketed through veterinary practices.

Dechra serves veterinary markets across Europe, North America, Australia, New Zealand and other international regions. The company expanded through product development, licensing agreements and acquisitions before being acquired by EQT in 2023, after which it became privately owned and its shares were delisted from the London Stock Exchange.

Key Stats

• Today's Range: $46.90 to $46.90
• 50-Day Range: $46.90 to $46.90
• 52-Week Range: $30.00 to $47.40
• Volume: N/A
• Average Volume: 1,687 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:DCHPF
• CIK: N/A
• Web: dechra.com
• Phone: 441606814730
• Fax: N/A
• Employees: 2,457
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A